 | 
Analysts| Firm | Analyst | | Barclays Capital | Jim Birchenough, M.D. | | Citi Investment Research | Lucy Lu, M.D. | | Collins Stewart | Salveen J. Kochnover | | Credit Suisse Securities | Michael Aberman, M.D. | | Jefferies & Company | Thomas Wei | | Oppenheimer & Co. Inc. | Brian Abrahams, M.D. | | RBC Capital Markets | Jason Kantor, Ph.D. | | Rodman & Renshaw Equity Research | Simos Simeonidis, Ph.D. | | Summer Street Research Partners | Jon Stephenson | | Thomas Weisel Partners LLC | Stephen Willey |
|
| Rigel Pharmaceuticals Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Rigel Pharmaceuticals Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Rigel Pharmaceuticals Inc. or its management. Rigel Pharmaceuticals Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
|  |